Pasithea Therapeutics KTTA Price Prediction

The determination to procure Pasithea Therapeutics is entirely contingent on your individualistic risk tolerance. As you may discern, Pasithea Therapeutics's value has experienced an escalation of 0.88% during the preceding 24 hours, and Pasithea Therapeutics has incurred a growth of 41.28% over the prior 30-day duration. Consequently, the determination of whether or not to invest in Pasithea Therapeutics will hinge on whether such an investment aligns with your trading aspirations.

It appears that the mean value of Pasithea Therapeutics may potentially surge to $1.58 by the end of this year. Looking at Pasithea Therapeutics's prospects in a more extended five-year timeline, the stock could potentially growth to as much as $1.52. However, given the market's unpredictability, it is vital to conduct thorough research before investing any funds into a particular company or asset.

Based on the our new experimental Pasithea Therapeutics forecast, the price of Pasithea Therapeutics will fall by -0.82% over the next week and reach $1.14 by January 21, 2026.

Based on the our new experimental Pasithea Therapeutics forecast, the price of Pasithea Therapeutics will increase by 2.8% over the next month and reach $1.18 by February 13, 2026.

As per our most recent prediction on Pasithea Therapeutics's value in 2026, KTTA is anticipated to fluctuate within the range of $1.12 and $1.58. However, it is crucial to bear in mind that the stock market is exceptionally unstable, and this projected Pasithea Therapeutics price forecast fails to consider sudden and extreme price fluctuations.

Pasithea Therapeutics's future appears to be on an upward trend, with an maximum price of $1.52 projected after a period of five years. Based on the Pasithea Therapeutics forecast for 2031, Pasithea Therapeutics's value may potentially reach its highest peak of approximately $1.52, while its lowest peak is anticipated to be around $1.34.

Based on the our new experimental Pasithea Therapeutics price prediction simulation, KTTA’s value in 2026 expected to grow by 38.04% to $1.58 if the best happened. The price will be between $1.58 and $1.12 during 2026.

According to our latest experimental simulation for Pasithea Therapeutics price prediction, KTTA’s value could rise by 45.97% to $1.67 in 2027, assuming the most favorable conditions. The price is projected to fluctuate between $1.67 and $1.25 throughout the year.

Our new experimental Pasithea Therapeutics price prediction model suggests that KTTA’s value in 2028 could increase by 17.38% , reaching $1.34 in the best-case scenario. The price is expected to range between $1.34 and $0.96 during the year.

Based on our experimental forecast model, Pasithea Therapeutics's value may experience a 3.9% growth in 2029, potentially reaching $1.19 under optimal conditions. The predicted price range for 2029 lies between $1.19 and $0.97.

Using our new experimental simulation for Pasithea Therapeutics price predictions, KTTA’s value in 2030 is expected to rise by 26.96% , reaching $1.46 in the best scenario. The price is forecasted to range between $1.46 and $1.03 over the course of 2030.

Our experimental simulation indicates that Pasithea Therapeutics’s price could grow by 32.23% in 2031, potentially hitting $1.52 under ideal conditions. The price will likely fluctuate between $1.52 and $1.34 during the year.

Based on the findings from our latest experimental Pasithea Therapeutics price prediction, KTTA could see a 63.59% rise in value, reaching $1.88 if the most positive scenario plays out in 2032. The price is expected to stay within a range of $1.88 and $1.47 throughout the year.

According to our experimental Pasithea Therapeutics price prediction, KTTA’s value is anticipated to rise by 118.36% in 2033, with the highest potential price being $2.51. Throughout the year, KTTA’s price could range from $2.51 and $1.88.

The results from our new Pasithea Therapeutics price prediction simulation suggest that KTTA may rise by 158.21% in 2034, potentially reaching $2.96 under the best circumstances. The predicted price range for the year is between $2.96 and $2.42.

Based on our experimental forecast for Pasithea Therapeutics’s price, KTTA could grow by 235.62% , with the value potentially hitting $3.85 in 2035. The expected price range for the year lies between $3.85 and $2.77.

Our recent Pasithea Therapeutics price prediction simulation suggests that KTTA’s value might rise by 385.68% in 2036, possibly reaching $5.58 if conditions are optimal. The expected price range for 2036 is between $5.58 and $3.64.

According to the experimental simulation, Pasithea Therapeutics’s value could rise by 547.19% in 2037, with a high of $7.44 under favorable conditions. The price is expected to fall between $7.44 and $5.46 over the course of the year.